 | • レポートコード：MRC2-11QY03585 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はカルシトニン遺伝子関連ペプチド1型受容体のグローバル市場について調査・分析したレポートです。種類別（AFAP-3、AGN-241689、CGRP、エレヌマブ、その他）市場規模、用途別（心血管、代謝障害、歯痛、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別カルシトニン遺伝子関連ペプチド1型受容体の競争状況、市場シェア ・世界のカルシトニン遺伝子関連ペプチド1型受容体市場：種類別市場規模 2015年-2020年（AFAP-3、AGN-241689、CGRP、エレヌマブ、その他） ・世界のカルシトニン遺伝子関連ペプチド1型受容体市場：種類別市場規模予測 2021年-2026年（AFAP-3、AGN-241689、CGRP、エレヌマブ、その他） ・世界のカルシトニン遺伝子関連ペプチド1型受容体市場：用途別市場規模 2015年-2020年（心血管、代謝障害、歯痛、その他） ・世界のカルシトニン遺伝子関連ペプチド1型受容体市場：用途別市場規模予測 2021年-2026年（心血管、代謝障害、歯痛、その他） ・北米のカルシトニン遺伝子関連ペプチド1型受容体市場分析：米国、カナダ ・ヨーロッパのカルシトニン遺伝子関連ペプチド1型受容体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのカルシトニン遺伝子関連ペプチド1型受容体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のカルシトニン遺伝子関連ペプチド1型受容体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのカルシトニン遺伝子関連ペプチド1型受容体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan Plc、Amgen Inc、Biohaven Pharmaceutical Holding Company Ltd、Eli Lilly and Company、Fortress Biotech Inc、Merck & Co Inc、Teva Pharmaceutical Industries Ltd、Vertex Pharmaceuticals Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Calcitonin Gene Related Peptide Type 1 Receptor Market
The global Calcitonin Gene Related Peptide Type 1 Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Calcitonin Gene Related Peptide Type 1 Receptor Scope and Market Size
Calcitonin Gene Related Peptide Type 1 Receptor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Calcitonin Gene Related Peptide Type 1 Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Calcitonin Gene Related Peptide Type 1 Receptor market is segmented into
AFAP-3
AGN-241689
CGRP
Erenumab
Others
Segment by Application, the Calcitonin Gene Related Peptide Type 1 Receptor market is segmented into
Cardiovascular
Metabolic Disorders
Dental Pain
Others
Regional and Country-level Analysis
The Calcitonin Gene Related Peptide Type 1 Receptor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Calcitonin Gene Related Peptide Type 1 Receptor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Calcitonin Gene Related Peptide Type 1 Receptor Market Share Analysis
Calcitonin Gene Related Peptide Type 1 Receptor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Calcitonin Gene Related Peptide Type 1 Receptor business, the date to enter into the Calcitonin Gene Related Peptide Type 1 Receptor market, Calcitonin Gene Related Peptide Type 1 Receptor product introduction, recent developments, etc.
The major vendors covered:
Allergan Plc
Amgen Inc
Biohaven Pharmaceutical Holding Company Ltd
Eli Lilly and Company
Fortress Biotech Inc
Merck & Co Inc
Teva Pharmaceutical Industries Ltd
Vertex Pharmaceuticals Inc
1 Study Coverage
1.1 Calcitonin Gene Related Peptide Type 1 Receptor Product Introduction
1.2 Market Segments
1.3 Key Calcitonin Gene Related Peptide Type 1 Receptor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate by Type
1.4.2 AFAP-3
1.4.3 AGN-241689
1.4.4 CGRP
1.4.5 Erenumab
1.4.6 Others
1.5 Market by Application
1.5.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate by Application
1.5.2 Cardiovascular
1.5.3 Metabolic Disorders
1.5.4 Dental Pain
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size, Estimates and Forecasts
2.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue 2015-2026
2.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales 2015-2026
2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Calcitonin Gene Related Peptide Type 1 Receptor Competitor Landscape by Players
3.1 Calcitonin Gene Related Peptide Type 1 Receptor Sales by Manufacturers
3.1.1 Calcitonin Gene Related Peptide Type 1 Receptor Sales by Manufacturers (2015-2020)
3.1.2 Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Manufacturers (2015-2020)
3.2 Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Manufacturers
3.2.1 Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Manufacturers (2015-2020)
3.2.2 Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Calcitonin Gene Related Peptide Type 1 Receptor Revenue in 2019
3.2.5 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Calcitonin Gene Related Peptide Type 1 Receptor Price by Manufacturers
3.4 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturing Base Distribution, Product Types
3.4.1 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Calcitonin Gene Related Peptide Type 1 Receptor Product Type
3.4.3 Date of International Manufacturers Enter into Calcitonin Gene Related Peptide Type 1 Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Type (2015-2020)
4.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2015-2020)
4.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type (2015-2020)
4.1.3 Calcitonin Gene Related Peptide Type 1 Receptor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast by Type (2021-2026)
4.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Type (2021-2026)
4.2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Type (2021-2026)
4.2.3 Calcitonin Gene Related Peptide Type 1 Receptor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Application (2015-2020)
5.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2015-2020)
5.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Application (2015-2020)
5.1.3 Calcitonin Gene Related Peptide Type 1 Receptor Price by Application (2015-2020)
5.2 Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast by Application (2021-2026)
5.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Application (2021-2026)
5.2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Application (2021-2026)
5.2.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Calcitonin Gene Related Peptide Type 1 Receptor by Country
6.1.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country
6.1.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Type
6.3 North America Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Application
7 Europe
7.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor by Country
7.1.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country
7.1.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Type
7.3 Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor by Region
8.1.1 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region
8.1.2 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Type
8.3 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Calcitonin Gene Related Peptide Type 1 Receptor by Country
9.1.1 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country
9.1.2 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Type
9.3 Central & South America Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor by Country
10.1.1 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country
10.1.2 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Type
10.3 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Corporation Information
11.1.2 Allergan Plc Description and Business Overview
11.1.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
11.1.5 Allergan Plc Related Developments
11.2 Amgen Inc
11.2.1 Amgen Inc Corporation Information
11.2.2 Amgen Inc Description and Business Overview
11.2.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
11.2.5 Amgen Inc Related Developments
11.3 Biohaven Pharmaceutical Holding Company Ltd
11.3.1 Biohaven Pharmaceutical Holding Company Ltd Corporation Information
11.3.2 Biohaven Pharmaceutical Holding Company Ltd Description and Business Overview
11.3.3 Biohaven Pharmaceutical Holding Company Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
11.3.5 Biohaven Pharmaceutical Holding Company Ltd Related Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Description and Business Overview
11.4.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
11.4.5 Eli Lilly and Company Related Developments
11.5 Fortress Biotech Inc
11.5.1 Fortress Biotech Inc Corporation Information
11.5.2 Fortress Biotech Inc Description and Business Overview
11.5.3 Fortress Biotech Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
11.5.5 Fortress Biotech Inc Related Developments
11.6 Merck & Co Inc
11.6.1 Merck & Co Inc Corporation Information
11.6.2 Merck & Co Inc Description and Business Overview
11.6.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
11.6.5 Merck & Co Inc Related Developments
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
11.7.5 Teva Pharmaceutical Industries Ltd Related Developments
11.8 Vertex Pharmaceuticals Inc
11.8.1 Vertex Pharmaceuticals Inc Corporation Information
11.8.2 Vertex Pharmaceuticals Inc Description and Business Overview
11.8.3 Vertex Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
11.8.5 Vertex Pharmaceuticals Inc Related Developments
11.1 Allergan Plc
11.1.1 Allergan Plc Corporation Information
11.1.2 Allergan Plc Description and Business Overview
11.1.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
11.1.5 Allergan Plc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Calcitonin Gene Related Peptide Type 1 Receptor Market Estimates and Projections by Region
12.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Regions 2021-2026
12.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Regions 2021-2026
12.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast (2021-2026)
12.2.1 North America: Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast (2021-2026)
12.2.2 North America: Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast (2021-2026)
12.2.3 North America: Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast by Country (2021-2026)
12.3 Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast (2021-2026)
12.3.1 Europe: Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast (2021-2026)
12.3.2 Europe: Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast (2021-2026)
12.3.3 Europe: Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast by Region (2021-2026)
12.5 Latin America Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast (2021-2026)
12.5.1 Latin America: Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast (2021-2026)
12.5.2 Latin America: Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast (2021-2026)
12.5.3 Latin America: Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Calcitonin Gene Related Peptide Type 1 Receptor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Calcitonin Gene Related Peptide Type 1 Receptor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Calcitonin Gene Related Peptide Type 1 Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Calcitonin Gene Related Peptide Type 1 Receptor Market Segments
Table 2. Ranking of Global Top Calcitonin Gene Related Peptide Type 1 Receptor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AFAP-3
Table 5. Major Manufacturers of AGN-241689
Table 6. Major Manufacturers of CGRP
Table 7. Major Manufacturers of Erenumab
Table 8. Major Manufacturers of Others
Table 9. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Regions (2015-2020)
Table 13. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Manufacturers (2015-2020)
Table 16. Global Calcitonin Gene Related Peptide Type 1 Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Calcitonin Gene Related Peptide Type 1 Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Calcitonin Gene Related Peptide Type 1 Receptor as of 2019)
Table 18. Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Calcitonin Gene Related Peptide Type 1 Receptor Price (2015-2020) (USD/Pcs)
Table 21. Calcitonin Gene Related Peptide Type 1 Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Calcitonin Gene Related Peptide Type 1 Receptor Product Type
Table 23. Date of International Manufacturers Enter into Calcitonin Gene Related Peptide Type 1 Receptor Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 26. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Type (2015-2020)
Table 27. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Type (2015-2020)
Table 29. Calcitonin Gene Related Peptide Type 1 Receptor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 31. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Application (2015-2020)
Table 32. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2015-2020) (K Pcs)
Table 33. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2015-2020)
Table 34. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2015-2020)
Table 36. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 37. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2015-2020)
Table 38. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 39. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2015-2020)
Table 40. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2015-2020)
Table 42. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2015-2020)
Table 44. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2015-2020)
Table 46. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2015-2020)
Table 56. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2015-2020)
Table 60. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2015-2020)
Table 62. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2015-2020)
Table 72. Allergan Plc Corporation Information
Table 73. Allergan Plc Description and Major Businesses
Table 74. Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Allergan Plc Product
Table 76. Allergan Plc Recent Development
Table 77. Amgen Inc Corporation Information
Table 78. Amgen Inc Description and Major Businesses
Table 79. Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Amgen Inc Product
Table 81. Amgen Inc Recent Development
Table 82. Biohaven Pharmaceutical Holding Company Ltd Corporation Information
Table 83. Biohaven Pharmaceutical Holding Company Ltd Description and Major Businesses
Table 84. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Biohaven Pharmaceutical Holding Company Ltd Product
Table 86. Biohaven Pharmaceutical Holding Company Ltd Recent Development
Table 87. Eli Lilly and Company Corporation Information
Table 88. Eli Lilly and Company Description and Major Businesses
Table 89. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Eli Lilly and Company Product
Table 91. Eli Lilly and Company Recent Development
Table 92. Fortress Biotech Inc Corporation Information
Table 93. Fortress Biotech Inc Description and Major Businesses
Table 94. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Fortress Biotech Inc Product
Table 96. Fortress Biotech Inc Recent Development
Table 97. Merck & Co Inc Corporation Information
Table 98. Merck & Co Inc Description and Major Businesses
Table 99. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Merck & Co Inc Product
Table 101. Merck & Co Inc Recent Development
Table 102. Teva Pharmaceutical Industries Ltd Corporation Information
Table 103. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 104. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Teva Pharmaceutical Industries Ltd Product
Table 106. Teva Pharmaceutical Industries Ltd Recent Development
Table 107. Vertex Pharmaceuticals Inc Corporation Information
Table 108. Vertex Pharmaceuticals Inc Description and Major Businesses
Table 109. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Vertex Pharmaceuticals Inc Product
Table 111. Vertex Pharmaceuticals Inc Recent Development
Table 112. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 113. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share Forecast by Regions (2021-2026)
Table 114. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 115. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share Forecast by Regions (2021-2026)
Table 116. North America: Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. North America: Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Europe: Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Europe: Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Asia Pacific: Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Region (2021-2026) (K Pcs)
Table 121. Asia Pacific: Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 122. Latin America: Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Latin America: Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Middle East and Africa: Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Middle East and Africa: Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key Calcitonin Gene Related Peptide Type 1 Receptor Players
Table 130. Calcitonin Gene Related Peptide Type 1 Receptor Customers List
Table 131. Calcitonin Gene Related Peptide Type 1 Receptor Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Calcitonin Gene Related Peptide Type 1 Receptor Product Picture
Figure 2. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type in 2020 & 2026
Figure 3. AFAP-3 Product Picture
Figure 4. AGN-241689 Product Picture
Figure 5. CGRP Product Picture
Figure 6. Erenumab Product Picture
Figure 7. Others Product Picture
Figure 8. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application in 2020 & 2026
Figure 9. Cardiovascular
Figure 10. Metabolic Disorders
Figure 11. Dental Pain
Figure 12. Others
Figure 13. Calcitonin Gene Related Peptide Type 1 Receptor Report Years Considered
Figure 14. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size 2015-2026 (US$ Million)
Figure 15. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales 2015-2026 (K Pcs)
Figure 16. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region (2015-2020)
Figure 18. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region in 2019
Figure 19. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region (2015-2020)
Figure 20. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region in 2019
Figure 21. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Calcitonin Gene Related Peptide Type 1 Receptor Revenue in 2019
Figure 23. Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type (2015-2020)
Figure 25. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Type in 2019
Figure 26. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Type (2015-2020)
Figure 27. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Type in 2019
Figure 28. Global Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Price Range (2015-2020)
Figure 29. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application (2015-2020)
Figure 30. Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Application in 2019
Figure 31. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Application (2015-2020)
Figure 32. Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Application in 2019
Figure 33. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country in 2019
Figure 36. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country in 2019
Figure 37. U.S. Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Type in 2019
Figure 42. North America Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Application in 2019
Figure 43. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country in 2019
Figure 46. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country in 2019
Figure 47. Germany Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Type in 2019
Figure 58. Europe Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Application in 2019
Figure 59. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Region in 2019
Figure 62. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Region in 2019
Figure 63. China Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Type in 2019
Figure 86. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Application in 2019
Figure 87. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country in 2019
Figure 90. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country in 2019
Figure 91. Mexico Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Type in 2019
Figure 98. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Application in 2019
Figure 99. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue Market Share by Country in 2019
Figure 103. Turkey Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Type in 2019
Figure 110. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Market Share by Application in 2019
Figure 111. North America Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
N-ホルミルペプチド受容体2の世界市場（～2026年） Market Analysis and Insights: Global N-Formyl Peptide Receptor 2 Market The global N-Formyl Peptide Receptor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global N-Formyl Peptide Receptor 2 Scope and Market Size N-Formyl …- グルカゴン様ペプチド2受容体の世界市場（～2026年） Market Analysis and Insights: Global Glucagon Like Peptide 2 Receptor Market The global Glucagon Like Peptide 2 Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glucagon Like Peptide 2 Receptor Scope and Market…
- カルシトニン（サケ）の世界市場（～2026年） Market Analysis and Insights: Global Calcitonin (salmon) Market The global Calcitonin (salmon) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Calcitonin (salmon) Scope and Market Size Calcitonin (salmon) market is seg…
- ペプチド胃腸障害治療薬の世界市場（～2026年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…
- ペプチド感染症治療薬の世界市場（～2026年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …